Clinical Trials Directory

Trials / Unknown

UnknownNCT02653339

Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a controlled clinical trials about traditional Chinese medicine named Qufeng Shengshi Fang,which consisted of cicada slough,bombyx batryticatus,radix angelicae,radix sileris,honeysuckle flower,forsythia,lithospermum and radix glycyrrhizae,and Loratadine on treatment of Allergic Rhinitis.There are 180 Patients with allergic rhinitis recruited from Department of Allergy and Traditional Chinese.To carry on statistical analysis of the result of the self and between-group cross-reference by two questionnaires filled before and after treatment.

Conditions

Interventions

TypeNameDescription
DRUGQufeng Shengshi Fang and LoratadineThe patients with allergic rhinitis are divided into two groups, one is experimental group, and the other is control group. The experimental group patients are treated with Qufeng by oral, 200ml two times a day and Loratadine by oral,10mg QD
DRUGLoratadineThe patients with allergic rhinitis are divided into two groups, one is experimental group, and the other is control group. The control group patients are treated with Loratadine by oral, 10mg QD

Timeline

Start date
2016-06-01
Primary completion
2018-03-01
Completion
2018-08-01
First posted
2016-01-12
Last updated
2016-04-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02653339. Inclusion in this directory is not an endorsement.